Quest Diagnostics (DGX) Misses Q4 EPS by 3c, Revenues; Offers FY19 EPS/Revenue Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. NAVN
4. HUMA
5. USO
6. CHWY
7. SPCX
8. cASY
9. TSLA
10. HNGE

Go back to Quest Diagnostics (DGX) Misses Q4 EPS by 3c, Revenues; Offers FY19 EPS/Revenue Guidance Below Consensus

Quest Diagnostics (DGX) PT Lowered to $100 at Baird

February 15, 2019 10:15 AM EST

Baird analyst Eric Coldwell lowered the price target on Quest Diagnostics (NYSE: DGX) to $100.00 (from $106.00) while maintaining a Outperform rating following the company's 4Q. Revenue missed the lowered November IR day target by ~$40M. $35M of downside due to additional reserve for payer denials,... More